Navigation Links
CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
Date:1/17/2012

SEATTLE, Jan. 17, 2012 /PRNewswire/ -- CompleGen, Inc. announced today that they have executed a non-exclusive services agreement regarding CompleGen's XenoGene™ technology.  Boehringer Ingelheim's discovery team will apply the technology to explore targets that are not easily accessible by other discovery platforms.

CompleGen's XenoGene™ technology uses the power of genetics to identify allosteric inhibitors that are selective for specific protein targets.

"We are very pleased to be working with Boehringer Ingelheim to open pathways for therapeutics that have proved to be elusive previously," commented Pauline Gee, CompleGen's VP Business Development.

About CompleGen

CompleGen is a drug discovery company that uses its proprietary discovery platform, XenoGene™ technology to identify and develop selective inhibitors for difficult targets.  With its small molecule library, CompleGen has identified potent allosteric inhibitors for targets where other discovery platforms have failed.  These allosteric inhibitors have been shown to be efficacious and well tolerated in animals.  www.complegen.com

Contact:
Pauline Gee, PhD
Vice President, Business Development
CompleGen, Inc.
1124 Columbia Street, Suite 662
Seattle, WA 98104
pgee@complegen.com
+1.303.961.1773


'/>"/>
SOURCE CompleGen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Incisive Surgical Announces Breakthrough Peer Review Clinical Study
2. Molnlycke Health Care U.S. Announces Senior Management Change
3. Zimmer Announces Acquisition of Synvasive Technology, Inc.
4. MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit
5. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
6. Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology
7. Practice Fusion Announces New Funding to Support EMR Growth in 2012
8. LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool
9. BNA Books Announces the Publication of the 2011 Cumulative Supplement to "Pharmaceutical Law: Regulation of Research, Development, and Marketing"
10. NewCardio Announces Changes in Board of Directors and Executive Management
11. RSB Spine, LLC, Announces United States Patent Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):